Evoke Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 4
- Market Cap
- $3.3M
- Website
- http://www.evokepharma.com
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Evoke Pharma
- Target Recruit Count
- 205
- Registration Number
- NCT02025725
- Locations
- 🇺🇸
Atlanta Gastroenterology Associates, Marietta, Georgia, United States
🇺🇸Kinston Medical Specialist Clinical Research Office, Kinston, North Carolina, United States
🇺🇸Southwest Gastroenterology, Oak Lawn, Illinois, United States
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Evoke Pharma
- Target Recruit Count
- 53
- Registration Number
- NCT02025751
- Locations
- 🇺🇸
The Center for Gastrointestinal Disorders, Hollywood, Florida, United States
🇺🇸Central Arizone Medical Associates/Clinical Research Advantage, Mesa, Arizona, United States
🇺🇸Advanced Medical Research, Port Orange, Florida, United States
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Evoke Pharma
- Target Recruit Count
- 287
- Registration Number
- NCT00845858
- Locations
- 🇺🇸
Impact Clinical Trials, Los Angeles, California, United States
🇺🇸Theda Oaks Endoscopy Center, San Antonio, Texas, United States
🇺🇸Consultants for Clinical Research, Cincinnati, Ohio, United States
© Copyright 2024. All Rights Reserved by MedPath